Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Go back to Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update
(NASDAQ: DARE) Delayed: 2.09 +0.04 (1.95%)
Previous Close $2.05    52 Week High
Open $2.02    52 Week Low
Day High $2.14    P/E N/A 
Day Low $2.02    EPS
Volume 56,642